日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

DS-1594 menin抑制剂治疗复发/难治性急性白血病的1/2期研究

Senapati, Jayastu; Konopleva, Marina; Issa, Ghayas C; Jabbour, Elias; Kadia, Tapan; DiNardo, Courtney; Borthakur, Gautam; Pemmaraju, Naveen; Short, Nicholas J; Yilmaz, Musa; Deshmukh, Indraneel; Alvarez, Joie; Loghavi, Sanam; Tang, Guilin; Abbas, Hussein A; Andreeff, Michael; Bhalla, Kapil; Midde, Narasimha M; Said, Nabil; Noyalis, Amy; Mires, Derek E; Ning, Jing; Xiao, Lianchun; Ravandi, Farhad; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Daver, Naval G

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

恢复TP53-Y220C突变型急性髓系白血病中p53野生型构象

Bing Z Carter ,Po Yee Mak ,Edward Ayoub ,Xiaogang Wu ,Baozhen Ke ,Yuki Nishida ,Andrew Futreal ,Lauren B Ostermann ,Andrea D Bedoy ,Steffen Boettcher ,Courtney D DiNardo ,Anna Puzio-Kuter ,Masha V Poyurovsky ,Arnold Levine ,Michael Andreeff

Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

维奈托克联合FLAG-IDA方案诱导和巩固治疗新诊断、复发或难治性急性髓系白血病的长期疗效

DiNardo, Courtney D; Jen, Wei-Ying; Takahashi, Koichi; Kadia, Tapan M; Loghavi, Sanam; Daver, Naval G; Xiao, Lianchun; Reville, Patrick K; Issa, Ghayas C; Short, Nicholas J; Sasaki, Koji; Wang, Sa A; Mullin, Jillian K; Pierce, Sherry; Bradley, Corey; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Ferrajoli, Alessandra; Swaminathan, Mahesh; Ohanian, Maro; Abbas, Hussein A; Hammond, Danielle; Burger, Jan; Haddad, Fadi; Montalban-Bravo, Guillermo; Chien, Kelly; Masarova, Lucia; Yilmaz, Musa; Jain, Nitin; Andreeff, Michael; Garcia-Manero, Guillermo; Kornblau, Steven; Ravandi, Farhad; Jabbour, Elias; Konopleva, Marina Y; Kantarjian, Hagop M

Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia

双重靶向 EZH2 和 EZH1 可促使白血病干细胞退出静止状态,并增强急性髓系白血病的化疗效果。

Akiyama, Hiroki; Nishida, Yuki; Chang, Kyung Hee; Bedoy, Andrea D; Muftuoglu, Muharrem; Ma, Wencai; Basyal, Mahesh; Hirschi, Zoe; Honma, Daisuke; Tsutsumi, Shinji; Wang, Jing; Zhang, Weiguo; Huang, Xuelin; Rampal, Raajit K; Oluwole, Olalekan O; Bixby, Dale Lee; Daver, Naval G; Andreeff, Michael

Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias

Quizartinib 和 Milademetan 联合抑制 FLT3-ITD 和 MDM2 对 FLT3-ITD 突变/TP53 野生型急性髓系白血病具有协同作用

Zhang, Weiguo; Li, Li; Muftuoglu, Muharrem; Basyal, Mahesh; Togashi, Noriko; Iwanaga, Koichi; Tanzawa, Fumie; Numata, Masashi; Bixby, Dale L; Erba, Harry P; Podoltsev, Nikolai; Schiller, Gary J; Kumar, Prasanna; Lesegretain, Arnaud; Isoyama, Takeshi; Seki, Takahiko; Daver, Naval; Andreeff, Michael

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

阿扎胞苷、维奈托克和马格罗利单抗治疗新诊断和复发难治性急性髓系白血病:Ib/II期研究及相关性分析

Daver, Naval; Senapati, Jayastu; Kantarjian, Hagop M; Wang, Bofei; Reville, Patrick K; Loghavi, Sanam; Yilmaz, Musa; DiNardo, Courtney D; Kadia, Tapan M; Yassouf, Mhd Yousuf; Maiti, Abhishek; Arora, Sankalp; Montalban Bravo, Guillermo; Tang, Guilin; Borthakur, Gautam; Sasaki, Koji; Pemmaraju, Naveen; Alvarez, Joie; Nogueras Gonzalez, Graciela M; Ning, Jing; Issa, Ghayas C; Konopleva, Marina; Andreeff, Michael; Ravandi, Farhad; Garcia-Manero, Guillermo; Abbas, Hussein A

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

一项针对既往未接受治疗的骨髓增生异常综合征患者的阿扎胞苷联合伊匹木单抗、纳武利尤单抗或伊匹木单抗联合纳武利尤单抗的II期临床试验

Bouligny, Ian M; Montalban-Bravo, Guillermo; Sasaki, Koji; Daver, Naval; Jabbour, Elias; Alvarado, Yesid; DiNardo, Courtney D; Ravandi, Farhad; Borthakur, Gautam; Bose, Prithviraj; Pemmaraju, Naveen; Kornblau, Steven; Kadia, Tapan; Masarova, Lucia; Takahashi, Koichi; Andreeff, Michael; Bazinet, Alexandre; Yang, Hui; Kanagal-Shamanna, Rashmi; Hosing, Chitra; Pierce, Sherry; Meyer, Meghan; Huang, Xuelin; Garcia-Manero, Guillermo

GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function

GD3合成酶通过调节线粒体功能驱动乳腺癌细胞对p53诱导的细胞凋亡产生抵抗力。

Vivek Anand ,Fouad El-Dana ,Natalia Baran ,Jenny Borgman ,Zheng Yin ,Hong Zhao ,Stephen T Wong ,Michael Andreeff ,V Lokesh Battula

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer

使用纳西他单抗靶向GD2可克服三阴性乳腺癌中GD3合成酶驱动的免疫抑制

Vivek Anand # ,Bolutyfe Oderinde # ,Maryam Siddiqui ,Anudishi Tyagi ,Jenny Borgman ,Chong Wu ,Michael Andreeff ,V Lokesh Battula

Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation

新诊断的伴有FLT3酪氨酸激酶结构域突变的急性髓系白血病患者的预后:NPM1共突变的预后意义

Arora, Sankalp; Jen, Wei-Ying; Yilmaz, Musa; Deshmukh, Indraneel; Senapati, Jayastu; Loghavi, Sanam; Issa, Ghayas C; Short, Nicholas J; Kadia, Tapan M; DiNardo, Courtney D; Borthakur, Gautam; Jabbour, Joseph; Pemmaraju, Naveen; Andreeff, Michael; Takahashi, Koichi; Bhalla, Kapil; Popat, Uday; Shpall, Elizabeth J; Oran, Betul; Abbas, Hussein A; Garcia-Manero, Guillermo; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval